Capricor Therapeutics, Inc. · 3 weeks ago
Post-Marketing Quality Compliance Associate
Capricor Therapeutics is a biotechnology company focused on advancing cell and exosome-based therapies for rare diseases. The Post-Marketing Quality Compliance Associate will conduct internal and external audits to ensure compliance with regulations and standards, collaborating with various departments to drive continuous improvement in quality systems.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Internal Audits: Plan, conduct, and report risk-based GxP audits across manufacturing, QC, labs, validation, and supply chain
Supplier Audits: Lead and support vendor audits and monitor ongoing supplier performance, as needed
Audit Execution: Develop audit agendas, checklists, and sampling strategies aligned with regulatory expectations
Reporting & CAPA: Issue clear audit reports, classify findings, and track CAPA effectiveness to closure
Inspection Readiness: Support regulatory inspection readiness
Gap Assessments: Assess compliance against regulations and industry standards and recommend improvements
Cross-Functional Partnership: Collaborate with QA/QC, Manufacturing, Regulatory, Supply Chain, and IT to strengthen quality systems
Metrics & Communication: Maintain audit schedules, dashboards, and communicate status and trends to management
Quality Improvement: Support SOP development, training, and continuous improvement initiatives
Additional Support: Willing to support activities related to post-marketing safety and surveillance and additional responsibilities as needed
Qualification
Required
Education: Bachelor's degree in a scientific or technical field (e.g., Chemistry, Biology, Engineering) or equivalent experience
Experience: 2–5 years of auditing experience within biopharma, biotech, medical devices, or related regulated industry, including audits against quality system elements (Deviation, CAPA, Change Control, Training, Document Control)
Regulatory Knowledge: Working knowledge of FDA 21 CFR Parts 210/211, ICH Q-series, EU GMP, and GxP principles
Communication: Strong writing skills and attention to detail; able to produce clear, evidence-based audit reports
Technical Proficiency: Proficiency with risk-based auditing, root cause analysis, and CAPA effectiveness verification
Stakeholder Management: Excellent communication and stakeholder management skills; comfortable engaging at all levels
Preferred
Certification: Certified Quality Auditor (CQA) – ASQ, or equivalent certification; candidates without certification must demonstrate the ability and willingness to obtain it within a defined timeframe
Vendor Oversight: Experience auditing CMOs/CDMOs and complex supply chains
Digital/Data: Background with data integrity, CSV, Annex 11, and Part 11 assessments
Specialized Manufacturing: Exposure to biologics, cell & gene therapy, aseptic processing, or sterile manufacturing
Post-Marketing: Knowledge of ISO 9001/13485 and quality systems related to post-marketing safety and surveillance (as applicable)
Company
Capricor Therapeutics, Inc.
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives.
Funding
Current Stage
Public CompanyTotal Funding
$329.5MKey Investors
Nippon ShinyakuNational Institutes of HealthCalifornia Institute for Regenerative Medicine
2025-12-05Post Ipo Equity· $150M
2024-10-17Post Ipo Equity· $75M
2024-09-17Post Ipo Equity· $15M
Recent News
2026-01-09
Company data provided by crunchbase